Anne-Marie Duliege
2017
In 2017, Anne-Marie Duliege earned a total compensation of $1.1M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,000 |
|---|---|
| Option Awards | $393,545 |
| Salary | $450,000 |
| Other | $3,354 |
| Total | $1,071,899 |
Duliege received $450K in salary, accounting for 42% of the total pay in 2017.
Duliege also received $225K in non-equity incentive plan, $393.5K in option awards and $3.4K in other compensation.
Rankings
In 2017, Anne-Marie Duliege's compensation ranked 8,657th out of 14,666 executives tracked by ExecPay. In other words, Duliege earned more than 41.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,657 out of 14,666 | 41st |
Division Manufacturing | 3,292 out of 5,772 | 43rd |
Major group Chemicals And Allied Products | 1,110 out of 2,075 | 47th |
Industry group Drugs | 882 out of 1,731 | 49th |
Industry Pharmaceutical Preparations | 689 out of 1,333 | 48th |
Source: SEC filing on April 4, 2018.
Duliege's colleagues
We found five more compensation records of executives who worked with Anne-Marie Duliege at Rigel Pharmaceuticals in 2017.
2017
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2017
Dolly Vance
Rigel Pharmaceuticals
General Counsel
2017
Ryan Maynard
Rigel Pharmaceuticals
Chief Financial Officer
2017
Eldon Mayer
Rigel Pharmaceuticals
Executive Vice President, Chief Commercial Officer
2017
Esteban Masuda
Rigel Pharmaceuticals